A citation-based method for searching scientific literature

Isabelle Guilleret, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar. Int J Cancer 2002
Times Cited: 172







List of co-cited articles
957 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
212
8

TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.
Janet C Lindsey, Ed C Schwalbe, Sandeep Potluri, Simon Bailey, Daniel Williamson, Steven C Clifford. Acta Neuropathol 2014
35
22


Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation.
Liang Liu, Sabita N Saldanha, Mitchell S Pate, Lucy G Andrews, Trygve O Tollefsbol. Genes Chromosomes Cancer 2004
49
14

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
7

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
631
7

Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.
Jiyue Zhu, Yuanjun Zhao, Shuwen Wang. Protein Cell 2010
54
12

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
7

How shelterin protects mammalian telomeres.
Wilhelm Palm, Titia de Lange. Annu Rev Genet 2008
7

Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Kerry A Pettigrew, Richard N Armstrong, Hilary A A Colyer, Shu-Dong Zhang, Irene Maeve Rea, Rhiannon E Jones, Duncan M Baird, Ken I Mills. Genes Chromosomes Cancer 2012
22
31

Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
Jee-Hye Choi, Soo Hyun Park, Jina Park, Borae G Park, Seong-Jae Cha, Kwang-Hoon Kong, Kwang-Ho Lee, Ae Ja Park. Biochem Biophys Res Commun 2007
27
25



Telomere elongation in immortal human cells without detectable telomerase activity.
T M Bryan, A Englezou, J Gupta, S Bacchetti, R R Reddel. EMBO J 1995
981
7

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
572
7

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
7

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
7

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
103
7

Reactivation of telomerase in cancer.
Semih Can Akincilar, Bilal Unal, Vinay Tergaonkar. Cell Mol Life Sci 2016
81
8

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Na Wang, Hanna Kjellin, Anastasios Sofiadis, Omid Fotouhi, C Christofer Juhlin, Martin Bäckdahl, Jan Zedenius, Dawei Xu, Janne Lehtiö, Catharina Larsson. Oncotarget 2016
29
24


Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
72
9

Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
Josh Lewis Stern, Richard D Paucek, Franklin W Huang, Mahmoud Ghandi, Ronald Nwumeh, James C Costello, Thomas R Cech. Cell Rep 2017
38
18

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
127
7

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
228
7

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Ricardo Leão, Joana Dias Apolónio, Donghyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo-Branco. J Biomed Sci 2018
76
9

Regulation of the human telomerase reverse transcriptase gene.
Anne-Lyse Ducrest, Henrietta Szutorisz, Joachim Lingner, Markus Nabholz. Oncogene 2002
157
6

Genetic and epigenetic modulation of telomerase activity in development and disease.
Liang Liu, Serene Lai, Lucy G Andrews, Trygve O Tollefsbol. Gene 2004
94
6

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Andreas Widschwendter, Hannes M Müller, Michael M Hubalek, Annemarie Wiedemair, Heidi Fiegl, Georg Goebel, Elisabeth Mueller-Holzner, Christian Marth, Martin Widschwendter. Gynecol Oncol 2004
56
10

Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.
Yuanyuan Li, Liang Liu, Lucy G Andrews, Trygve O Tollefsbol. Int J Cancer 2009
115
6

Telomerase activation by histone deacetylase inhibitor in normal cells.
M Takakura, S Kyo, Y Sowa, Z Wang, N Yatabe, Y Maida, M Tanaka, M Inoue. Nucleic Acids Res 2001
137
6


TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.
Hideyuki Arita, Yoshitaka Narita, Hirokazu Takami, Shintaro Fukushima, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, Soichiro Shibui, Koichi Ichimura. Acta Neuropathol 2013
47
12

hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Magnus Borssén, Inger Cullman, Ulrika Norén-Nyström, Christer Sundström, Anna Porwit, Erik Forestier, Göran Roos. Exp Hematol 2011
22
27


Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
191
6

hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells.
Cristina Valls-Bautista, Stéphanie Bougel, Carme Piñol-Felis, Joan Viñas-Salas, Jean Benhattar. Oncol Lett 2011
9
66

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
363
6

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
258
6

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
Matthias Simon, Ismail Hosen, Konstantinos Gousias, Sivaramakrishna Rachakonda, Barbara Heidenreich, Marco Gessi, Johannes Schramm, Kari Hemminki, Andreas Waha, Rajiv Kumar. Neuro Oncol 2015
110
6

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
960
6

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
287
6

Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
Hong Zhang, Xiaoling Weng, Junyi Ye, Lin He, Daizhan Zhou, Yun Liu. Clin Res Hepatol Gastroenterol 2015
25
24


Structure and function of telomeres.
E H Blackburn. Nature 1991
5

PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells.
Stéphanie Bougel, Stéphanie Renaud, Richard Braunschweig, Dmitri Loukinov, Herbert C Morse, Fred T Bosman, Victor Lobanenkov, Jean Benhattar. J Pathol 2010
21
23

hTERT methylation and expression in gastric cancer.
Carolina Oliveira Gigek, Mariana Ferreira Leal, Patricia Natalia Oliveira Silva, Luara Carolina Frias Lisboa, Eleonidas Moura Lima, Danielle Queiroz Calcagno, Paulo Pimentel Assumpção, Rommel Rodriguez Burbano, Marilia de Arruda Cardoso Smith. Biomarkers 2009
34
14

Epigenetics in cancer.
Manel Esteller. N Engl J Med 2008
5

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Ralf Gertler, Robert Rosenberg, Dominik Stricker, Jan Friederichs, Axel Hoos, Martin Werner, Kurt Ulm, Bernhard Holzmann, Hjalmar Nekarda, Joerg-Ruediger Siewert. J Clin Oncol 2004
132
5

Telomerase expression predicts unfavorable outcome in osteosarcoma.
Robert P Sanders, Rachid Drissi, Catherine A Billups, Najat C Daw, Marcus B Valentine, Jeffrey S Dome. J Clin Oncol 2004
70
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.